Chapter 21 Clinical chemistry at the extremes of age
Old age
• different patterns of disease
• different presentation of disease
• greater likelihood of more than one illness
• decline in normal functions with age
There is no precise definition of what constitutes ‘elderly’: the changes in physiological function that occur in older people correlate only loosely with chronological age and can occur much earlier in individuals with conditions characterized by premature ageing (e.g. progeria). Nevertheless, many conditions are more common in the elderly than in younger adults; examples of such conditions of particular relevance to clinical biochemistry include diabetes mellitus (see Chapter 11), osteoporosis (see p. 260), Paget’s disease of bone (see p. 262) and thyroid diseases (see p. 166). Furthermore, the presentation of diseases in the elderly may be different from that usually seen in younger people. Thus myocardial infarction may present with confusion, consequent to a reduction in cerebral blood flow, rather than with chest pain; the presenting feature of diabetes mellitus may be one of its complications, for example ischaemic ulceration, rather than polyuria and thirst. Case histories 21.1–21.4 provide more detailed examples of these problems.
Elderly people, particularly if they have impaired mobility or live alone, may have poor nutrition and are especially prone to vitamin D deficiency (see p. 328). Also, they are more likely than younger people to be taking medication, often multiple, which may have adverse effects in addition to the expected therapeutic effects.
Reference ranges
Such changes in normal function mean that the reference ranges applicable to healthy adults may not be applicable to the elderly, while the increased incidence of many diseases with increasing age makes it difficult to obtain data on healthy people. Ideally, laboratories should construct age-related reference ranges for age-dependent analytes (where appropriate: it is not, for example, for glucose) (Fig. 21.1), but in practice this is not always done.
Screening
The higher prevalence of many diseases in the elderly provides some of the justification for screening programmes. If a condition has a high prevalence in a population, the predictive value of a positive test is much higher than if it is low (see Chapter 1). Such screening may be carried out in general practice, at over-60s clinics, in older people’s assessment centres or on admission to hospital. The biochemical investigations that should form part of such a screen (Fig. 21.2) reflect the diseases that are of particular concern in this age group, some of which have been mentioned above. Plasma potassium is included because diuretics are frequently prescribed in the elderly and, according to the type used, may cause hypokalaemia or hyperkalaemia. The possible influence of intercurrent disease or drugs (particularly lithium and amiodarone) on tests of thyroid status must be borne in mind. The results of such tests may erroneously suggest thyroid disease in a patient who is ill for some other reason (sick euthyroid syndrome) and it is best to avoid doing these tests at such a time. In the UK, it is recommended that all individuals engaging with healthcare should undergo a simple screen for malnutrition. This is particularly important in the elderly.
Case history 21.2
Investigations
Serum: digoxin (12 h after previous dose) | 2.5 µg/L |
potassium | 3.0 mmol/L |
urea | 11.2 mmol/L |
creatinine | 160 µmol/L (eGFR 29 mL/min/1.73 m2) |
Case history 21.3
Case history 21.4
In addition to the fracture, a radiograph showed typical features of osteomalacia.
Investigations
Serum: calcium | 1.75 mmol/L |
phosphate | 0.70 mmol/L |
alkaline phosphatase | 440 U/L |
albumin | 30 g/L |
corrected calcium | 1.95 mmol/L |